-
-
-
-
-
-
-
RedHill Biopharma's (RDHL) RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial
-
-
-
-
-
-
-
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients
-
-
-
-
1,161,185 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

